BioSpace News Archive

Bio NC

Ribometrix Raises $7.5 Million in Seed Funding to Advance Platform for Discovering and Developing Small Molecule Modulators of RNA to Treat Human Diseases

The investment was led by SV Health Investors and Hatteras Venture Partners.

October 31, 2017

·

1 min read

Biotech Beach

International Stem Cell Corporation Receives Key Stem Cell Patent in Australia

International Stem Cell Corporation announces ISCO’s patent covering methods for generating HLA homozygous parthenogenetic human stem cell lines from unfertilized eggs has been issued in Australia.

October 31, 2017

·

3 min read

Policy

Ivantis Completes Pre-Market Approval Submission for the Hydrus Microstent for Minimally Invasive Glaucoma Surgery

Ivantis announced today that it has submitted its final Pre-Market-Approval module to the FDA for market approval.

October 31, 2017

·

3 min read

BioForest

LumiThera Closes Series B Round of Financing

LumiThera raised $5.5M to support further development of its LT-300 device for the treatment for dry Age-related Macular Degeneration.

October 31, 2017

·

2 min read

Biotech Bay

Here Are the Top 10 In Vitro Diagnostic Companies

The companies are ranked by revenues of clinical diagnostic test instruments, reagents and supplies.

October 31, 2017

·

2 min read

Lombard Medical Reports First Half and Third Quarter 2017 Financial Results

During 2017, Lombard has refocused sales and marketing activities to concentrate on markets that yield the most revenue potential at a reasonable sales cost.

October 31, 2017

·

6 min read

Policy

Teva Wins Generic Uceris Patent Trial

Teva today announced that the United States District Court for the District of Delaware has ruled in the Company’s favor in patent litigation involving Teva’s abbreviated new drug application (ANDA) directed to a generic version of Valeant’s Uceris® (budesonide ER) tablets.

October 31, 2017

·

7 min read

Drug Development

Rhythm Announces Preliminary Data from Phase II Study of Setmelanotide for Treatment of Bardet-Biedl Syndrome

The results are being presented at the ObesityWeek 2017 meeting held October 29 - November 2, 2017.

October 31, 2017

·

4 min read

Drug Development

Samumed Initiates Phase Ib Trial of SM04755 for Treatment of Psoriasis

Top-line data is expected by Q2 2018.

October 31, 2017

·

2 min read

Business

Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy

Dr. Lalonde was previously Medical Director, Neurosciences for Roche France in Paris.

October 31, 2017

·

4 min read